Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
32
The experimental group will receive 2 standardized hypnosis sessions via the "superhero costume" technique performed during this collective therapeutic education program, completed by a reinforcement through the practice of self-hypnosis at home guided by the listening of an audio recording
CHU de la Réunion
Saint-Denis, Reunion
Asses the patient recruitment rate
The recruitment rate is the proportion of patients recruited into the pilot study: number of patients included/number of patients to whom the study was proposed.
Time frame: 24 months
Assess patient compliance with self-hypnosis practice
Assess patients' adherence to self-hypnosis practice at home, on a self-reported basis, using an adherence log in the experimental arm by: * The adherence rate at M1 * The variation in the adherence rate over time
Time frame: At 1 month, 3 months, and 6 months after inclusion
Patient lost sight of
Evaluate the rate of patient who has been lost sight of(M1, M3, M6) in both arms, measured by the proportion of patients lost sight of/number of patients included at baseline
Time frame: At 1 month, 3 months, and 6 months after inclusion
Patient satisfaction
Assess patient satisfaction with the hypnosis program in the experimental arm using a satisfaction questionnaire
Time frame: At 1 month, 3 months, and 6 months after inclusion
Improvements to the hypnosis program
Describe possible improvements to the hypnosis program in the experimental arm at M6 through focus group interviews with a group of volunteers aged 8-11 and a group of volunteers aged 12-17.
Time frame: At 6 months after inclusion
Effectiveness
Evaluate the effectiveness of a hypnosis program (exploratory) * On the control of atopic dermatitis ( The change in the mean AD control score, measured by the ADCT) * On the severity of atopic dermatitis (The change in the mean AD severity score, measured by the PO-SCORAD)
Time frame: At 1 month, 3 months, and 6 months after inclusion
Parents' overall impression
Assess parents' overall impression of their child's AD progress with the hypnosis program, via a questionnaire
Time frame: At 1 month, 3 months, and 6 months after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.